Andala Health Logo.
Referring Providers
Book Appointment
Andala Health Logo.
Book Appointment

Psychotherapy

Psychotherapy

GET A FREE CONSULT

Discovery Therapy Options

Psychotherapy at Andala® is a structured, evidence-based approach to treating a range of mental health conditions. Our licensed clinicians provide individualized therapy for depression, anxiety, trauma-related disorders, and other complex presentations.


Sessions take place virtually or in our outpatient clinic and are tailored to each patient’s unique goals and needs. Therapy may be provided independently or as part of a broader treatment plan to support long-term emotional stability and growth.

Schedule A Free Consult

This field is for validation purposes and should be left unchanged.
Name(Required)
This field is hidden when viewing the form
Name

By submitting this form you agree to be contacted via text/email/phone. Reply “stop” to opt-out at any time.

*Insurance rates are subject to increase based on your individual copay, deductibles, and coinsurance. For accurate insurance coverage of ketamine, please call us at 1-210-783-0582 or fill out the online form below.

Therapy FAQs

Does insurance cover Spravato?
Our clinic, along with our dedicated Spravato Care Coordinator, collaborates with patients’ insurance providers to secure prior authorization for Spravato treatment. Once a provider recommends Spravato during a consultation, we streamline the process to help patients access the care they need.
Spravato is FDA-approved in the treatment of treatment-resistant depression in adult patients who have not benefited from treatment plans that used other antidepressant medicines, as well as adults with major depressive disorder who experience suicidal thoughts or behaviors. Given risk factors including dissociation and sedation post-administration, the FDA requires that Spravato be prescribed by a physician and administered under medical supervision.

If you’re about to have your first Spravato treatment at Andala, there are a few tips we recommend to all new Spravato patients:

  • Patients undergoing Spravato treatment are not permitted to drive afterward. We encourage arranging a ride with a friend or loved one, or utilizing ride-share services like Uber or Lyft. For those opting for ride-shares, a waiver must be signed in the clinic prior to treatment.
  • Try to get plenty of sleep the night before.
  • Bring a book, headphones or something for entertainment during the post-treatment monitoring phase.
  • Spravato, like all depression treatments, works best when combined with talk therapy.

Andala’s Reconnect Lounge is a comfortable space for patients to spend time reflecting and relaxing after administering Spravato under the supervision of a member of our care team.

How often you take Spravato will depend on your particular treatment plan. Any patient taking Spravato should only do so under medical supervision. Generally, Spravato is administered two times a week during the first 30 days of treatment, then once a week during the next 30 days of treatment. Ongoing administration of Spravato may occur on a weekly basis or every two weeks, as clinically indicated.

The FDA has approved Spravato for administration under medical supervision at certain clinics. Patients can self-administer Spravato at Andala clinics or another certified Spravato treatment center, and only under the guidance and supervision of a health care professional.

Spravato is effective in multiple clinical trials in the treatment of depression. In one study, Spravato plus an oral antidepressant showed superior improvement in symptoms over an oral antidepressant plus a placebo after four weeks. The treatment difference between Spravato and the placebo was also clear after just 24 hours. Spravato has also been shown to delay time to relapse in some patients.
Spravato has not been FDA-approved for the treatment of anxiety. Ongoing research is needed to confirm the efficacy of Spravato in the treatment of anxiety. Ketamine, a medicine related to the esketamine used in Spravato, has been used in the treatment of some forms of anxiety. However, FDA approval and research into its efficacy are still pending. Patients interested in esketamine and/or ketamine to address anxiety can consult with their doctor to determine what approach works best for their needs.
It is imperative that you disclose all other medications you are taking when working with your Andala care team. Any medication may influence how Spravato reacts with your body, either reducing the effectiveness of the medicine or increasing side effects.

Possible Spravato interactions may include but are not limited to, psychostimulants (e.g., amphetamines, methylphenidate, modafinil, armodafinil) and monoamine oxidase inhibitors (MAOIs), which may increase blood pressure. Benzodiazepines, opioids, or alcohol may increase sedation and make the treatments.

Sources

Scroll to Top
Skip to content